IRIS

In advanced epithelial ovarian cancer patients, the standard of care is primary debulking surgery, followed by first-line chemotherapy often with bevacizumab addiction. In this context, some experiences have shown that a comprehensive treatment approach to surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) could improve the prognosis.

Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer / Paris, I.; Cianci, S.; Vizzielli, G.; Fagotti, A.; Ferrandina, G.; Gueli Alletti, S.; Costantini, B.; Cosentino, F.; Capoluongo, Ettore Domenico; Pasqualoni, M.; Scambia, G.. - In: INTERNATIONAL JOURNAL OF HYPERTHERMIA. - ISSN 0265-6736. - 35:1(2018), pp. 370-374. [10.1080/02656736.2018.1503346]

Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer

Capoluongo;
2018

Abstract

In advanced epithelial ovarian cancer patients, the standard of care is primary debulking surgery, followed by first-line chemotherapy often with bevacizumab addiction. In this context, some experiences have shown that a comprehensive treatment approach to surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) could improve the prognosis.
2018
Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer / Paris, I.; Cianci, S.; Vizzielli, G.; Fagotti, A.; Ferrandina, G.; Gueli Alletti, S.; Costantini, B.; Cosentino, F.; Capoluongo, Ettore Domenico; Pasqualoni, M.; Scambia, G.. - In: INTERNATIONAL JOURNAL OF HYPERTHERMIA. - ISSN 0265-6736. - 35:1(2018), pp. 370-374. [10.1080/02656736.2018.1503346]
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/779595
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 29
social impact